Explore Watchlists Pricing

TOWA PHARMACEUTICAL CO.,LTD. (4553) Balance sheet

Market cap

¥194.7B

P/E ratio

8.7x

Towa Pharmaceutical manufactures and sells generic drugs to hospitals and distributors in Japan, Europe, and North America through its own facilities and subsidiaries.

Summary Financials Dividends History Ownership Workforce

Income statement Balance sheet Cash flow Other

	2014/03	2015/03	2016/03	2017/03	2018/03	2019/03	2020/03	2021/03	2022/03	2023/03	2024/03	2025/03	2026/03
Cash and cash equivalents	-	3,009	20,526	9,444	14,247	26,762	18,713	22,915	32,830	24,257	29,650	45,471	45,306
Marketable securities, current	-	3,198	5,000	6,000	10,999	4,999	-	-	-	-	-	-	-
Accounts receivable, net	-	22,669	19,818	19,627	24,185	27,905	35,191	38,122	42,896	46,795	62,916	61,449	63,283
Inventories	-	16,677	21,039	22,510	17,609	17,591	24,130	30,083	32,098	44,457	48,986	44,770	54,255
Total current assets	-	66,642	95,132	86,552	95,377	108,206	120,375	137,290	166,864	182,990	217,718	247,306	267,343
Property, plant and equipment, net	-	50,577	58,770	74,904	76,989	73,663	79,330	85,898	100,857	127,004	153,642	168,423	170,643
Marketable securities, non-current	-	1,900	564	531	427	451	455	519	464	676	641	871	957
Total non-current assets	-	54,544	61,719	78,695	81,947	80,597	107,763	108,378	163,071	188,357	212,934	223,517	207,946
Total assets	-	121,187	156,851	165,247	177,325	188,803	228,138	245,668	329,935	371,347	430,653	470,823	475,290
Accounts payable	-	12,577	6,954	5,309	5,385	6,466	9,585	10,000	14,834	17,272	15,652	17,918	21,309
Short-term debt	-	1,490	1,740	1,740	850	850	21,368	1,111	49,335	3,677	3,112	4,699	7,100
Long-term debt, current	-	2,505	2,033	2,681	4,249	6,396	6,767	7,181	8,022	7,527	10,120	18,023	21,772
Total current liabilities	-	31,054	31,262	34,601	35,904	37,177	69,468	51,516	115,073	78,529	80,118	87,939	96,867
Total non-current liabilities	-	20,085	54,984	55,701	61,501	59,854	54,020	77,552	82,692	155,923	194,641	211,259	200,318
Total liabilities	-	51,139	86,246	90,302	97,405	97,032	123,489	129,069	197,766	234,453	274,759	299,198	297,186
Retained earnings	-	57,893	63,821	67,879	72,816	84,734	97,171	108,629	122,131	121,232	134,452	150,502	151,815
Stockholders' equity	60,147	70,048	70,605	74,945	79,920	91,771	104,649	116,599	132,169	136,894	155,893	171,625	178,103
Working capital	-